Veterinary Cardiology Market Forecast: Navigating the Next Decade of Growth

The global veterinary cardiology market was valued at USD 2,787.0 million in 2024 and is projected to reach USD 4,468.3 million by 2030, reflecting a CAGR of 8.4% from 2025 to 2030. A significant driver for this market is the high prevalence of cardiological disorders among companion animals, especially dogs.

Research indicates that approximately 10% of all dogs seen in primary care veterinary settings are diagnosed with heart disease, with this figure escalating to over 60% in older dogs. Among these cases, myxomatous mitral valve disease (MMVD) is the most prevalent, accounting for 75% of canine heart disease cases in the U.S., primarily affecting the heart valves. Another important condition, dilated cardiomyopathy (DCM), directly affects the heart muscle. The widespread occurrence of these disorders highlights the increasing demand for advanced diagnostics, therapeutics, and specialized animal care, which in turn fuels the growth of the veterinary cardiology market.

Additionally, the rising awareness of preventive health care has led pet owners to invest more in their pets' health to enhance their overall well-being. The increasing spending on animal care is a notable factor driving market growth. According to an article published in February 2024 by the Bureau of Labor Statistics, the cost of veterinary services surged by 7.5% from September 2022 to September 2023. This trend is indicative of growing pet ownership, heightened awareness of pet health, and advancements in veterinary diagnostics and treatments. As pet owners prioritize specialized care, including cardiology services, this surge in spending underpins the demand for innovative solutions and expanded offerings in animal cardiology.

Key Market Trends & Insights

• North America: North America led the overall global veterinary cardiology market, capturing the largest revenue share of 38.48% in 2024. This dominance is attributed to advanced veterinary healthcare infrastructure, high pet ownership rates, and increasing awareness of animal health issues. The region's robust research and development activities further contribute to the availability of cutting-edge diagnostic and therapeutic options, making it a pivotal area for market growth. 

• Asia Pacific: The Asia Pacific region is anticipated to exhibit the fastest compound annual growth rate (CAGR) from 2025 to 2030. This growth is driven by rising disposable incomes, increasing pet ownership, and heightened awareness of pet health among consumers. Furthermore, the expansion of veterinary clinics and hospitals, along with improved access to advanced veterinary care, will support the market's rapid growth in this region. 

• Companion Animals Segment: The companion animals segment dominated the market, accounting for over 67.28% of the total market share in 2024. This significant share reflects the growing trend of pet humanization, where pet owners view their animals as family members and prioritize their health and well-being. Increased spending on veterinary care, especially for dogs and cats, is a critical factor driving the expansion of this segment. 

• Congestive Heart Failure Segment: By indication, the congestive heart failure segment held a substantial market share of over 37.93% in 2024. This segment's dominance is primarily due to the high incidence of heart disease in older companion animals, particularly dogs. As veterinarians increasingly recognize the importance of early diagnosis and management of cardiac conditions, an increasing number of treatment options are being developed, further enhancing this segment's growth prospects. 

• Pharmaceuticals Segment: The pharmaceuticals segment emerged as the leading product category in 2024, reflecting its vital role in managing cardiological disorders in animals. This includes medications for heart failure, arrhythmias, and other cardiac conditions. The ongoing development of novel therapeutics and the increasing availability of specialized veterinary medications are key factors propelling the growth of this segment. Furthermore, pet owners’ willingness to invest in high-quality healthcare products for their pets reinforces the market's expansion.

Order a free sample PDF of the Veterinary Cardiology Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 2,787.0 Million

• 2030 Projected Market Size: USD 4,468.3 Million

• CAGR (2025-2030): 8.4%

• North America: Largest market in 2024

Key Players

• Boehringer Ingelheim International GmbH

• Jurox Pty Limited

• Ceva

• Merck & Co., Inc.

• IDEXX

• Apex Bio Medical

• SOUND

• General Electric Company

• FUJIFILM Holdings America Corporation

• ESAOTE SPA

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The veterinary cardiology market is on an upward trajectory, driven by the increasing incidence of heart disease in companion animals, particularly dogs. The market is supported by rising pet ownership and a greater focus on preventive health care, reflected in the growing expenditure on veterinary services. As more pet owners seek specialized cardiology care, the demand for advanced diagnostics and therapeutics will likely continue to expand, providing significant opportunities for growth within the market.